Latest Whitepapers

In this white paper, our marketing director of the America’s Kathy Macchiarola outlines the important decisions factors that are key requirements and help you select a benchtop system ideal for your situation and your needs.

The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.

The recent changes to the United States Pharmacopeia (USP) regarding requirements for elemental impurity testing has peaked interest into new ways to perform this testing. Combining these new requirements with the introduction of USP chapter <735> X-ray fluorescence spectrometry1 permits a new alternate method for quantifying elemental impurities in pharmaceutical materials.

Download this free white paper from Protein Simple to learn about the differences between MFI and how MFI provides crucial information about your protein therapeutic.

The accuracy and completeness of data is crucial for safe product development and to prevent serious implications regarding human health.

Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.

Promoting calorimetry-based studies on protein misfolding by developing treatments and prevention of aggregation-related diseases.

Here are some questions you should ask yourself as you begin evaluating
dynamic light scattering instruments.

This white paper summarizes a study comparing normal versus COPD lung fibroblasts and normal versus asthma lung fibroblasts to explore differences in gene expression among the donor samples.

Rapid, high-resolution characterization of liposome-insulin receptor complexes in various buffer systems by Nanoparticle Tracking Analysis